NYSEARCA:PBE Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News $58.48 -0.31 (-0.53%) (As of 09/20/2023 ET) Add Compare Share Share Today's Range$58.48▼$59.1150-Day Range$58.39▼$64.0552-Week Range$56.31▼$68.50Volume3,845 shsAverage Volume5,984 shsMarket Capitalization$232.16 millionAssets Under Management$231.51 millionDividend Yield0.02%Net Expense Ratio0.58% ProfileProfileChartHeadlinesHoldingsRatingsProfileChartHeadlinesHoldingsRatings About Invesco Biotechnology & Genome ETFPowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund’s investment adviser.Read More PBE Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBE ETF News HeadlinesSeptember 6, 2023 | finance.yahoo.comShould You Invest in the Invesco Biotechnology & Genome (PBE)?May 21, 2023 | finance.yahoo.comPBE Offers Exposure to Surging Catalent StockSeptember 21, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.March 24, 2023 | finance.yahoo.comInvesco Dynamic Biotechnology & Genome ETF (PBE)March 1, 2023 | benzinga.comInvesco Dynamic Biotech & Genome ETF (ARCA:PBE), Quotes and News SummaryFebruary 24, 2023 | seekingalpha.comPBE Invesco Dynamic Biotechnology & Genome ETFFebruary 16, 2023 | money.usnews.comVirtus LifeSci Biotech Clinical Trls ETFApril 16, 2022 | thestreet.comAmazon, Apple and Chipotle Too Pricey for Your Portfolio? There's an ETF for ThatSeptember 21, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.September 17, 2021 | news.yahoo.comWhite Biotechnology Competitor Analysis Report - Global Forecast to 2026See More Headlines Receive PBE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Biotechnology & Genome ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PBE Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Biotech & Genome Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$232.83 million Average Daily Volume$7,873.40 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Options OptionableN/A Short Interest13,000 shs Miscellaneous Outstanding Shares3,970,000Beta0.87 Creation Unit10,000 Creation Fee$500.00 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Invesco Biotechnology & Genome ETF ExpensesTypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.57%0.53%0.50%0.50%Other Expenses0.08%0.40%0.52%0.64%0.57%Total Expense0.58%0.72%0.69%0.74%0.69%Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%Net Expense0.58%0.61%0.59%0.57%0.57% Invesco Biotechnology & Genome ETF (PBE) Holdings & ExposureTop 10 PBE HoldingsUnited Therapeutics(NASDAQ:UTHR)Holding Weight: 5.59%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 5.22%QIAGEN NVHolding Weight: 5.07%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 4.96%Gilead Sciences(NASDAQ:GILD)Holding Weight: 4.85%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 4.69%Illumina(NASDAQ:ILMN)Holding Weight: 4.62%Biogen(NASDAQ:BIIB)Holding Weight: 4.32%CymaBay Therapeutics(NASDAQ:CBAY)Holding Weight: 3.70%Halozyme Therapeutics(NASDAQ:HALO)Holding Weight: 3.48%PBE Sector ExposurePBE Industry ExposureFull Holdings Details Key ExecutivesH. Bruce BondChairman of the Board of Trustee, Chief Executive OfficerBruce T. DuncanChief Financial Officer, TreasurerKevin R. GustafsonChief Compliance OfficerKeith A OvittSecretaryRonn R. BaggeTrusteeMarc M KoleTrusteeD. Mark McMillanTrusteePhilip M. Nussbaum MbaTrusteeDonald H. WilsonTrusteeMore ExecutivesSimilar ETFsInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHSPDR S&P Pharmaceuticals ETFNYSEARCA:XPHDirexion Daily Healthcare Bull 3x SharesNYSEARCA:CUREInvesco Pharmaceuticals ETFNYSEARCA:PJPInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHInstitutional OwnershipOsaic Holdings Inc.Bought 715 shares on 8/21/2023Ownership: 0.426%CreativeOne Wealth LLCBought 7,599 shares on 8/16/2023Ownership: 0.719%Royal Bank of CanadaBought 1,449 shares on 8/15/2023Ownership: 1.412%Stifel Financial CorpSold 243 shares on 8/15/2023Ownership: 0.457%IHT Wealth Management LLCSold 225 shares on 8/15/2023Ownership: 0.087%View All Institutional Transactions PBE ETF - Frequently Asked Questions How have PBE shares performed in 2023? Invesco Biotechnology & Genome ETF's stock was trading at $63.4970 at the beginning of 2023. Since then, PBE stock has decreased by 7.9% and is now trading at $58.4775. View the best growth stocks for 2023 here. What does PBE invest in? Invesco Biotechnology & Genome ETF is a equity fund issued by Invesco. PBE focuses on health care investments and follows the Dynamic Biotech & Genome Intellidex Index. The fund's investments total to approximately $232.83 million assets under management. What stocks does Invesco Biotechnology & Genome ETF hold? PBE invests in 31 holdings. Some of the stocks in their portfolio include United Therapeutics (UTHR), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), BioMarin Pharmaceutical (BMRN), Illumina (ILMN), Biogen (BIIB), CymaBay Therapeutics (CBAY), Halozyme Therapeutics (HALO) and Dynavax Technologies (DVAX). What is the management fee for Invesco Biotechnology & Genome ETF? Invesco Biotechnology & Genome ETF's management fee is 0.50% and has other expenses of 0.08%. The net expense ratio for PBE is 0.58%. What other stocks do shareholders of Invesco Biotechnology & Genome ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Mastercard (MA), Hello Group (MOMO) and ONEOK (OKE). What is Invesco Biotechnology & Genome ETF's stock symbol? Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE." Who are Invesco Biotechnology & Genome ETF's major shareholders? Invesco Biotechnology & Genome ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (1.98%), Royal Bank of Canada (1.41%), LPL Financial LLC (1.34%), CreativeOne Wealth LLC (0.72%), YHB Investment Advisors Inc. (0.58%) and Stifel Financial Corp (0.46%). How do I buy shares of Invesco Biotechnology & Genome ETF? Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Invesco Biotechnology & Genome ETF's stock price today? One share of PBE stock can currently be purchased for approximately $58.48. How much money does Invesco Biotechnology & Genome ETF make? Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) has a market capitalization of $232.16 million. How can I contact Invesco Biotechnology & Genome ETF? Invesco Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The official website for the company is www.invescopowershares.com. The company can be reached via phone at +1-800-9830903. This page (NYSEARCA:PBE) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.